Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2023-2029

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

LPI (LP Information)' newest research report, the “Tuberculosis (TB) Diagnostics Industry Forecast” looks at past sales and reviews total world Tuberculosis (TB) Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis (TB) Diagnostics sales for 2023 through 2029. With Tuberculosis (TB) Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis (TB) Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Tuberculosis (TB) Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis (TB) Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis (TB) Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis (TB) Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis (TB) Diagnostics.

The global Tuberculosis (TB) Diagnostics market size is projected to grow from US$ 2572.8 million in 2022 to US$ 3540.9 million in 2029; it is expected to grow at a CAGR of 4.7% from 2023 to 2029.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%.

APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

In terms of product, Culture-based is the largest segment, with a share about 33%. And in terms of application, the largest application is Hospitals, followed by Diagnostic Laboratories.

This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis (TB) Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Culture-Based Diagnostics

Sputum Smear Microscopy

Rapid Molecular Diagnostics

Others

Segmentation by application

Diagnostic Laboratories

Hospitals

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Danaher

Roche

Thermo Fisher Scientific

BD

Abbott

Hologic

Qiagen

BioMerieux

Hain Lifescience

Oxford Immunotec

Please note: The report will take approximately 2 business days to prepare and deliver.